Publications by the researcher in collaboration with Tomas Sobrino Moreiras (32)

2014

  1. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  2. Quick adjustment of imaging tracer payload, for in vivo applications of theranostic nanostructures in the brain

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 10, Núm. 4, pp. 851-858

2011

  1. Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke

    Journal of Translational Medicine, Vol. 9

  2. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke

    Neurological Research, Vol. 33, Núm. 6, pp. 572-577

  3. Cd34 +progenitor cells likely are involved in the good functional recovery after intracerebral hemorrhage in humans

    Journal of Neuroscience Research, Vol. 89, Núm. 7, pp. 979-985

  4. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

  5. Los niveles de expresión de los receptores toll-like 2 y 4 en neutrófilos se asocian con el pronóstico de los pacientes con ictus isquémico

    Revista de Neurologia, Vol. 52, Núm. 1, pp. 12-19

  6. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: An experimental study

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1378-1386

  7. Proteomic analysis shows differential protein expression in endothelial progenitor cells between healthy subjects and ischemic stroke patients

    Neurological Research, Vol. 33, Núm. 10, pp. 1057-1063

  8. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome

    Thrombosis and Haemostasis, Vol. 105, Núm. 3, pp. 421-429

  9. Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1424-1431

  10. Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke

    Clinical Immunology, Vol. 139, Núm. 2, pp. 193-198